Author
Listed:
- Yu Nishida
- Shuhei Hosomi
- Hirokazu Yamagami
- Naoko Sugita
- Shigehiro Itani
- Tomomi Yukawa
- Koji Otani
- Yasuaki Nagami
- Fumio Tanaka
- Koichi Taira
- Noriko Kamata
- Tetsuya Tanigawa
- Toshio Watanabe
- Yasuhiro Fujiwara
Abstract
Objectives: Although tacrolimus is useful as an induction therapy in patients with ulcerative colitis (UC), information regarding the long-term outcome after tacrolimus therapy is insufficient. The aim of this study was to evaluate the clinical significance of the pretreatment neutrophil-to-lymphocyte ratio (NLR) as a prognostic factor in patients with UC receiving tacrolimus, to aid treatment selection. Materials and methods: Patients with moderate-to-severe active UC who received oral tacrolimus induction therapy and subsequent immunomodulatory maintenance therapy at our hospital between 2009 and 2017 and who showed clinical response at week 12, were retrospectively enrolled. Cox regression analysis was conducted to study the prognostic role of the pretreatment NLR. The combined impact of the NLR and other known prognostic factors was investigated with multivariate regression. Results: Among 45 patients included in this study, 21 patients experienced relapse during a median follow-up period of 16.6 months. Multivariate Cox regression analysis identified the pretreatment NLR (hazard ratio [HR]: 0.82, 95% confidence interval [CI]: 0.72–0.94, P
Suggested Citation
Yu Nishida & Shuhei Hosomi & Hirokazu Yamagami & Naoko Sugita & Shigehiro Itani & Tomomi Yukawa & Koji Otani & Yasuaki Nagami & Fumio Tanaka & Koichi Taira & Noriko Kamata & Tetsuya Tanigawa & Toshio , 2019.
"Pretreatment neutrophil-to-lymphocyte ratio predicts clinical relapse of ulcerative colitis after tacrolimus induction,"
PLOS ONE, Public Library of Science, vol. 14(3), pages 1-13, March.
Handle:
RePEc:plo:pone00:0213505
DOI: 10.1371/journal.pone.0213505
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0213505. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.